Rajesh Kumar
Stock Analyst at HSBC
(3.23)
# 1,019
Out of 4,862 analysts
21
Total ratings
60%
Success rate
12.66%
Average return
Main Sectors:
Stocks Rated by Rajesh Kumar
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LLY Eli Lilly and Company | Downgrades: Reduce | $1,150 → $700 | $819.36 | -14.57% | 2 | Apr 28, 2025 | |
| IQV IQVIA Holdings | Downgrades: Hold | $260 → $160 | $156.89 | +1.98% | 1 | Apr 25, 2025 | |
| KDP Keurig Dr Pepper | Upgrades: Buy | $36 → $42 | $33.02 | +27.20% | 1 | Apr 25, 2025 | |
| ABBV AbbVie | Upgrades: Buy | $185 | $191.08 | -3.18% | 3 | Jun 5, 2024 | |
| TMO Thermo Fisher Scientific | Maintains: Buy | $660 → $670 | $402.76 | +66.35% | 3 | Apr 30, 2024 | |
| DHR Danaher | Upgrades: Buy | $250 → $280 | $200.67 | +39.53% | 2 | Apr 17, 2024 | |
| UNH UnitedHealth Group | Upgrades: Hold | $460 | $313.53 | +46.72% | 2 | Apr 4, 2024 | |
| TEVA Teva Pharmaceutical Industries | Initiates: Buy | $13 | $16.99 | -23.48% | 1 | Dec 18, 2023 | |
| BMY Bristol-Myers Squibb Company | Upgrades: Hold | $55 → $53 | $49.75 | +6.53% | 2 | Oct 27, 2023 | |
| MRNA Moderna | Initiates: Reduce | $97 | $26.67 | +263.70% | 1 | Jul 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $124 | $106.57 | +16.36% | 1 | Jul 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $50 | $24.54 | +103.75% | 1 | Jul 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $123 | $81.71 | +50.53% | 1 | Jul 14, 2023 |
Eli Lilly and Company
Apr 28, 2025
Downgrades: Reduce
Price Target: $1,150 → $700
Current: $819.36
Upside: -14.57%
IQVIA Holdings
Apr 25, 2025
Downgrades: Hold
Price Target: $260 → $160
Current: $156.89
Upside: +1.98%
Keurig Dr Pepper
Apr 25, 2025
Upgrades: Buy
Price Target: $36 → $42
Current: $33.02
Upside: +27.20%
AbbVie
Jun 5, 2024
Upgrades: Buy
Price Target: $185
Current: $191.08
Upside: -3.18%
Thermo Fisher Scientific
Apr 30, 2024
Maintains: Buy
Price Target: $660 → $670
Current: $402.76
Upside: +66.35%
Danaher
Apr 17, 2024
Upgrades: Buy
Price Target: $250 → $280
Current: $200.67
Upside: +39.53%
UnitedHealth Group
Apr 4, 2024
Upgrades: Hold
Price Target: $460
Current: $313.53
Upside: +46.72%
Teva Pharmaceutical Industries
Dec 18, 2023
Initiates: Buy
Price Target: $13
Current: $16.99
Upside: -23.48%
Bristol-Myers Squibb Company
Oct 27, 2023
Upgrades: Hold
Price Target: $55 → $53
Current: $49.75
Upside: +6.53%
Moderna
Jul 14, 2023
Initiates: Reduce
Price Target: $97
Current: $26.67
Upside: +263.70%
Jul 14, 2023
Initiates: Buy
Price Target: $124
Current: $106.57
Upside: +16.36%
Jul 14, 2023
Initiates: Buy
Price Target: $50
Current: $24.54
Upside: +103.75%
Jul 14, 2023
Initiates: Hold
Price Target: $123
Current: $81.71
Upside: +50.53%